Oxybutynin Hydrochloride

盐酸奥昔布宁

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameOxybutynin Hydrochloride
Drug Alias Name奥昔布甯奥昔布宁盐酸盐奥斯必得宁盐酸羟丁宁Neoxy +[22] 
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsMenopausal symptomsHot FlashesUrinary Incontinence, Urge +[11] 
Global Approved IndicationsUrinary Incontinence, UrgeUrinary Bladder, Overactive
Approved Indications in ChinaUrinary Bladder, Overactive
Original Approved Country/TerritoryUnited States
Original Approved Date1975/07/16
Country/TerritoryCanadaUnited StatesFrance +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesTeva BvNational Cancer InstituteFarco-Pharma Gmbh +[4] 
Inactive CompaniesEastern Virginia Medical SchoolMylan Pharmaceuticals IncJanssen Pharmaceuticals Inc +[7] 
Active IndicationsUrinary Incontinence, UrgeUrinary Bladder, OveractiveSpinal Dysraphism +[4] 
Inactive IndicationsMenopausal symptomsHot FlashesUrinary Incontinence +[7] 

Other Information

ATC CodeG04BD04
Related LinksWikipediaDrugBankKEGG